Maravai LifeSciences Holdings, Inc. MRVI Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $165.92M-41.8% | $216.89M-32.7% | $243.57M-57.9% | $269.91M-52.9% | $285.05M-49.3% | ||
| $109.33M-16.2% | $104.41M-24.7% | $117.43M-24.1% | $123.68M-28.0% | $130.54M-29.8% | ||
| $172.95M-13.4% | $182.26M-8.8% | $191.85M-4.6% | $197.06M-1.3% | $199.73M+1.0% | ||
| $12.85M-25.3% | $14.61M-14.0% | $16.03M-3.8% | $16.43M-5.9% | $17.21M+0.8% | ||
| $8.98M-9.4% | $7.32M-27.2% | $9.7M-9.7% | $10.52M-4.6% | $9.92M-20.8% | ||
| $18.63M-17.7% | $18.57M-19.5% | $19.59M-14.8% | $19.72M-5.3% | $22.65M+11.9% | ||
| $55.04M-21.2% | $56.07M-23.9% | $60.84M-18.3% | $68.07M-10.1% | $69.83M-14.0% | ||
| $251.74M-33.1% | $296.25M-31.0% | $325.87M-52.0% | $359.76M-47.2% | $376.28M-43.7% | ||
| $146.93M-11.7% | $151.48M-7.9% | $158.62M-3.6% | $162.73M-1.7% | $166.43M+3.0% | ||
| $129.43M-19.0% | $129.43M-19.0% | $129.43M-24.7% | $129.43M-60.3% | $159.88M-51.0% | ||
| $144.89M-27.4% | $151.54M-22.3% | $185.88M-7.9% | $193.07M-6.8% | $199.58M-6.8% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $713.22M-25.7% | $770.58M-23.6% | $849.19M-33.6% | $896.97M-37.9% | $959.75M-33.6% | ||
| $30.97M+31.0% | $31.96M+207% | $41.01M+31,935% | $30.59M+575% | $23.63M+1,186% | ||
| $28.65M-35.8% | $36.57M-7.6% | $12.55M-67.7% | $16.44M-59.6% | $44.6M+353% | ||
| $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | $5.44M0.0% | ||
| $3.2M-8.6% | $3M-9.1% | $2.6M-10.3% | $2.6M-25.7% | $3.5M-16.7% | ||
| $42.62M-32.5% | $44.92M-21.2% | $61.57M-3.4% | $69.68M+1.5% | $63.16M+7.0% | ||
| $235.57M-18.6% | $286.33M-1.4% | $287.38M-44.3% | $288.44M-44.2% | $289.5M-44.1% | ||
| $29.87M-3.3% | $30.14M-3.1% | $30.41M-2.9% | $30.65M-2.8% | $30.88M-2.6% | ||
| $36.07M-18.0% | $36.48M-30.5% | $37.97M-30.0% | $38.19M-29.3% | $43.97M-25.0% | ||
| $344.13M-19.9% | $397.87M-7.7% | $417.33M-37.3% | $428.98M-36.1% | $429.48M-35.6% | ||
| $202.13M+8.2% | $199.18M+9.5% | $196.51M+11.9% | $191.38M+13.7% | $186.8M+38.9% | ||
| $6.39M-94.2% | $10.12M-92.8% | $45.8M-72.5% | $71.36M-73.0% | $110.95M-59.5% | ||
| $466K— | $524K— | $579K— | —— | —— | ||
| $157.52M-31.4% | $160.33M-36.4% | $186.42M-30.4% | $202.12M-40.2% | $229.66M-37.4% | ||
| $211.56M-29.6% | $212.38M-34.7% | $245.44M-28.8% | $265.86M-38.8% | $300.61M-26.8% | ||
| $713.22M-25.7% | $770.58M-23.6% | $849.19M-33.6% | $896.97M-37.9% | $959.75M-33.6% | ||
| $18.63M-17.7% | $18.57M-19.5% | $19.59M-14.8% | $19.72M-5.3% | $22.65M+11.9% | ||
| —— | —— | —— | —— | —— | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $144.89M-27.4% | $151.54M-22.3% | $185.88M-7.9% | $193.07M-6.8% | $199.58M-6.8% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $146.93M-11.7% | $151.48M-7.9% | $158.62M-3.6% | $162.73M-1.7% | $166.43M+3.0% | ||
| $40.24M-30.1% | $41.88M-30.0% | $49.4M-18.9% | $51.98M-18.1% | $57.58M-23.2% | ||
| $28.65M-35.8% | $36.57M-7.6% | $48.14M+23.7% | $50.2M+23.3% | $44.6M+26.0% | ||
| $28.65M-35.8% | $36.57M-7.6% | $48.14M+23.7% | $50.2M+23.3% | $44.6M+26.0% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $1.87M-44.7% | $2.47M-34.1% | $2.78M-62.0% | $3.08M-60.8% | $3.38M-59.9% | ||
| $270.88M-17.1% | $364.71M-3.2% | $367.94M-34.4% | $371.08M-34.0% | $326.65M-41.9% | ||
| —— | —— | —— | —— | —— | ||
| $1.1M— | $1M— | $400K— | $400K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $3.2M-8.6% | $3M-9.1% | $2.6M-10.3% | $2.6M-25.7% | $3.5M-16.7% | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| $157.52M-31.4% | $160.33M-36.4% | $186.42M-30.4% | $202.12M-40.2% | $229.66M-37.4% | ||
| —— | —— | —— | —— | —— | ||
| $1.1M— | $1M— | $400K— | $400K— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— | ||
| —— | —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Maravai LifeSciences Holdings, Inc.'s total assets?
- Maravai LifeSciences Holdings, Inc. (MRVI) holds $713.2M in total assets, down 25.7% year over year.
- How much debt does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. carries $270.9M in total debt against $211.6M of shareholders' equity, a debt-to-equity ratio of 1.28.
- How much cash does Maravai LifeSciences Holdings, Inc. have?
- Maravai LifeSciences Holdings, Inc. holds $165.9M in cash and equivalents.
- Can Maravai LifeSciences Holdings, Inc. cover its short-term obligations?
- Its current ratio is 5.91 — current assets exceed current liabilities.
- Where does Maravai LifeSciences Holdings, Inc.'s balance sheet data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
